IRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference

WINTER SPRINGS, Fla., Sept. 18, 2017 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference in New York, NY.  Mr. Susi and Mr. Scott are scheduled to present on Tuesday, September 26th at 3:25 pm Eastern Time.

Investors may listen to a live webcast and view a copy of the slide presentation online via the internet at http://www.iradimed.com/en-us/investors/index.php and selecting Events & Presentations.  The recorded webcast will be accessible online for at least 30 days.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in the development of MRI compatible medical devices. We are the only known provider of non-magnetic intravenous (IV) infusion pump systems that are specifically designed to be safe for use during magnetic resonance imaging (MRI) procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency (RF) interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated in order to remain immobile during an MRI scan.

Our 3880 MRI compatible patient…

Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *